Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Priavoid Logo
Priavoid CB Rank
814888
Heat Score
55
Priavoid GmbH develops clinical-stage therapies for neurodegenerative diseases using novel compounds targeting protein misfolding.
Founded
obfuscation
Private Düsseldorf, Nordrhein-Westfalen, Germany11-50 priavoid.com
Manufacturing
Medical
Pharmaceutical
Overview

Priavoid
Heat Score
55

Growth Score
pts
in past quarter
Heat Score 55
-17 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Priavoid

CB Rank
814888
Priavoid GmbH develops clinical-stage therapies for neurodegenerative diseases using novel compounds targeting protein misfolding.
Founded
obfuscation
Private Düsseldorf, Nordrhein-Westfalen, Germany11-50 priavoid.com
Manufacturing
Medical
Pharmaceutical

Key People

Details

Legal Name Priavoid GmbH
Operating Status Active
Company Type For Profit
Founders  Dieter Willbold, Ralph Zahn
Phone Number +49 211 942 522 98
Contact Email info@priavoid.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

PRI-002
A clinical-stage all-d-peptide therapeutic candidate targeting amyloid beta oligomers in Alzheimer's disease to dissolve toxic protein aggregates.
PRI-100
An all-d-peptide therapeutic candidate targeting alpha-synuclein oligomers in Parkinson's disease to disrupt toxic protein aggregation.

Research & Development

Priavoid is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 1

Employee Profiles

News

News and Press

News•Mar 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 18, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 22, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

273
-69.26%
 in past month

IT Spend

$286.8KThis year, Priavoid is projected to spend $286.8K on IT, according to Aberdeen.

Active Website Tech Count

13Priavoid is actively using 13 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  Euro.

Total IP

9The intellectual property of Priavoid includes 8 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Priavoid has 1 registered trademark in the 'Chemical substances' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Priavoid's headquarters? Priavoid is located in Düsseldorf, Nordrhein-Westfalen, Germany.Who are Priavoid's competitors? Alternatives and possible competitors to Priavoid may include Eli Lilly, Roche, and  Novartis.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|